Charles River’s sixth World Congress, “Drug Modalities Game Changers,” is part of our ongoing efforts to progress and raise awareness about how advanced modalities are disrupting drug development. This one-day global event took place in Cambridge, MA with sessions streamed live to the Cambridge, UK and San Francisco, CA satellite locations. This year's World Congress showcased how advanced modalities are shaping drug development through presentations from scientific distributors, panel discussions, and patient success stories. In case you missed it, the presentations are available for viewing below.
Welcome and Opening Remarks
Charles River World Congress Researcher Award
Small Molecule Sequestrants
AI and Digital Twins to Drive the Next Generation Drug Discovery and Development
Impact of Phosphoryl Guanidine on Oligonucleotide Pharmacology in Preclinical and Clinical Studies
Charles River World Congress Researcher Award Reunion Panel
Development of Therapeutic Antibodies
Emily Whitehead's Journey to CAR T
Terry Horgan Pioneer Award
We are equipped to help you navigate challenges along your drug discovery journey.

Terry Pirovolakis
Founder of CureSPG50

Tom Whitehead
Co-Founder Emily Whitehead Foundation

Julie Frearson
SVP Chief Scientific Officer
Charles River

Sonia Vallabh
Associated Scientist
Broad Institute

Eric Minikel
Associated Scientist
Broad Institute

David Hysong
Patient, Founder & Chief Executive Officer
SHEPHERD Therapeutics

Rich Horgan
Founder and CEO
Cure Rare Disease

Matthew Porteus
Professor of Definitive and Curative Medicine at Stanford University, Scientific founder of CRISPR T
Stanford University

Mike Byrne
Vice President, In Vivo and CNS Biology
Wave Life Sciences

Victor S. Goldmacher
Co-founder and Chief Scientific Officer
ImmuVia

Colby Souders
Chief Scientific Officer
BrickBio

Colin Hill
CEO
Aitia

Becky Schweighardt
Chief Scientific Officer
Grace Science

Shekar Shetty
Chief Executive Officer
Clear Scientific

Piercen Oliver
VP Research & Development
Clear Scientific

Sam Chuang
Director, Scientific Advisory Services
Charles River

Birgit Girshick
EVP Chief Operating Officer
Charles River